Authors:
Brown, JS
Vittinghoff, E
Kanaya, AM
Agarwal, SK
Hulley, S
Foxman, B
Citation: Js. Brown et al., Urinary tract infections in postmenopausal women: Effect of hormone therapy and risk factors, OBSTET GYN, 98(6), 2001, pp. 1045-1052
Citation: S. Hulley, Estrogens should not be initiated for the secondary prevention of coronaryartery disease: A debate, CAN J CARD, 16, 2000, pp. 10-12
Authors:
Grady, D
Wenger, NK
Herrington, D
Khan, S
Furberg, C
Hunninghake, D
Vittinghoff, E
Hulley, S
Citation: D. Grady et al., Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study, ANN INT MED, 132(9), 2000, pp. 689
Authors:
Hulley, S
Grady, D
Vittinghoff, E
Bush, T
Furberg, C
Herrington, C
Riggs, B
Citation: S. Hulley et al., Hormone replacement therapy for secondary prevention of coronary heart disease - Reply, J AM MED A, 281(9), 1999, pp. 796-797
Citation: S. Hulley, Is hormone substitution therapy (HST) beneficial as secondary prevention of coronary artery disease in the menopausal woman?, PRESSE MED, 27(36), 1998, pp. 1846-1846